Loading

Cell View

Cell Information

  PDX primary renal cell carcinoma

Overall DesignIn order to identify successful clonal propagation from patient to PDX samples and understand pathogenesis from primary to metastatic RCC, we performed whole-exome sequencing (WES, n=4) and matched aCGH (n=4) on bulk tumor samples. And we utilized single-cell RNA sequencing (scRNA-seq) to model and dissect functional heterogeneity acroass primary and metastatic RCC tumors. We checked whether of capturing live one cell, not more cells, in microfluidics by fluorescent microscopic observation. To construct RNA sequencing libraries, we performed further quality controls including adequate quantities and qualities of amplified transcriptomes respectively from single cells. Tumor cells from the parental mRCC (n=34), PDX-mRCC (n=36) and PDX-pRCC (n=46) were finally analyzed in this study after filtering out poor quality cells.
SummaryClear cell renal cell carcinoma (ccRCC) initiated from the renal epithelium is the most prevalent histological type of adult kidney cancers. Dissecting intratumoral heterogeneity (ITH) of ccRCC has leveraged to extend our knowledge on how primary tumors harboring driver mutations evolve and spread to other sites. The cellular fractions within and across the primary (pRCC) and metastatic RCC (mRCC) are heterogeneous in both their genetic and biological features determining the variability in clinical aggressiveness and sensitivity to the therapy. To achieve sustainable therapeutic benefit with targeted agents in mRCC, the effective target should focus on signaling pathways that are related to driver mutations occurred early in the clonal evolution of the disease and thus should be common to primary tumor and metastatic sites. Considering that extensive genetic heterogeneity may result in drug response variability among patients and treatment resistance, the tailored strategies for metastatic RCC is urgently needed. Here, we analyze single-cell RNA-seq (scRNA-seq) data from a matched primary RCC (pRCC) and lung metastasis (mRCC) to dissect ITH at the highest resolution to date with the objective of discovering the better therapeutic regimen.
Dataset viewGSE73121
PMID27139883

Samples in PDX primary renal cell carcinoma

Displaying 41-47 of 47 results.
SeriesSampleInstrumentOrganismTitleCell Source
GSE73121GSM1887293Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_87PDX primary renal cell carcinoma
GSE73121GSM1887294Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_88PDX primary renal cell carcinoma
GSE73121GSM1887295Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_89PDX primary renal cell carcinoma
GSE73121GSM1887296Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_90PDX primary renal cell carcinoma
GSE73121GSM1887297Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_91PDX primary renal cell carcinoma
GSE73121GSM1887299Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_93PDX primary renal cell carcinoma
GSE73121GSM1887301Illumina HiSeq 2500Homo sapiensPDX_pRCC_SC_94PDX primary renal cell carcinoma

Gene rank in PDX primary renal cell carcinoma

Displaying 18351-18360 of 18370 results.
Rank orderGene SymbolEnsembl ID
18351DDX43P2ENSG00000270763
18352RPAP2P1
18353TAS2R6PENSG00000270923
18354MTRNR2L2ENSG00000271043
18355BNIP3P28ENSG00000271095
18356TCEB1P33ENSG00000271278
18357NAPGP1
18358ABI1P1
18359BNIP3P17ENSG00000271524
18360ARF4P1ENSG00000271525